Renal artery embolization in severe nephrotic syndrome

Basit Öğe Kaydı
dc.contributor.authorSolak, Yalcin
dc.contributor.authorKoc, Osman
dc.contributor.authorUcar, Ramazan
dc.contributor.authorOzbek, Orhan
dc.contributor.authorErgenc, Hasan
dc.contributor.authorGaipov, Abduzhappar
dc.contributor.authorTurk, Suleyman
dc.date.accessioned2024-02-23T14:24:15Z
dc.date.available2024-02-23T14:24:15Z
dc.date.issued2016
dc.departmentNEÜen_US
dc.description.abstractIntroduction Severe nephrotic syndrome is associated with increased morbidity and mortality. Renal artery embolization (RAE) has been used in a number of renal diseases such as renal tumors, arteriovenous fistulas etc. However, data regarding benefits of RAE in patients with symptomatic severe proteinuria is limited. We decided to evaluate role of RAE in the setting of severe symptomatic nephrotic syndrome. Methods Eight patients who had undergone transcatheter renal artery embolization with polyvinyl alcohol (PVA) were included. Clinico-demographic characteristics as well as baseline laboratory data including level of proteinuria, serum albumin, C-reactive protein and LDL cholesterol levels were recorded for each patient. After RAE, outpatient clinic control laboratory values were also assessed. Findings All patients except one underwent bilateral RAE (four simultaneous or three sequential). Two patients experienced postembolization syndrome characterized by flank pain, fever, and leukocytosis, which was self-limited and responded to analgesics in all patients. There was no technical complications associated with RAE procedure. All patients became anuric except one. Serum albumin levels increased and serum LDL-cholesterol levels decreased considerably in treated patients. Discussion Renal artery embolization with the purpose of amelioration in nephrotic syndrome complications was effective and free of major technical complications in our patients.en_US
dc.identifier.doi10.1111/hdi.12397
dc.identifier.endpage413en_US
dc.identifier.issn1492-7535
dc.identifier.issn1542-4758
dc.identifier.issue3en_US
dc.identifier.pmid26833695en_US
dc.identifier.scopus2-s2.0-84978741608en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage407en_US
dc.identifier.urihttps://doi.org/10.1111/hdi.12397
dc.identifier.urihttps://hdl.handle.net/20.500.12452/13854
dc.identifier.volume20en_US
dc.identifier.wosWOS:000379825800014en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherWiley-Blackwellen_US
dc.relation.ispartofHemodialysis Internationalen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAmyloidosisen_US
dc.subjectProteinuriaen_US
dc.subjectHypoalbuminemiaen_US
dc.subjectRenal Artery Embolizationen_US
dc.subjectMedical Nephrectomyen_US
dc.subjectNephrotic Syndromeen_US
dc.titleRenal artery embolization in severe nephrotic syndromeen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu